Effect of Clenbuterol on Muscle Activity During Exercise in Standardbred Horses.
Authors: Rankins Ellen M, Salem Kayla, Manso Filho Helio C, Malinowski Karyn, McKeever Kenneth H
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: Clenbuterol and Muscle Activity in Standardbred Horses Despite widespread use of clenbuterol as a bronchodilator in equine performance medicine, uncertainty persists about how this β2-agonist influences neuromuscular function during exercise, particularly following acute dosing. Rankins and colleagues administered a single dose of clenbuterol (0.80 μg/kg) to eight Standardbred horses in a crossover design, collecting surface electromyography data from the extensor carpi radialis, semitendinosus, and longissimus dorsi during two minutes of treadmill exercise at 5 m/s, then quantified both signal amplitude (average rectified value) and frequency characteristics of peak muscle activation across 15 strides. No statistically significant differences emerged between clenbuterol and control conditions in either electromyographic amplitude or median frequency, suggesting that a single dose produces no detectable acute changes in motor recruitment patterns or muscle fibre activation properties. Whilst this null finding may reassure practitioners that short-term clenbuterol administration does not acutely disrupt normal muscular mechanics at submaximal intensities, the authors appropriately call for investigation of longer-term dosing regimens and higher exercise intensities, as chronic clenbuterol exposure has documented effects on muscle phenotype and performance that may not be captured by examining isolated acute responses.
Read the full abstract on PubMed
Practical Takeaways
- •A single dose of clenbuterol does not produce detectable changes in muscle activation during submaximal exercise, suggesting acute effects on muscle function may be limited in performance horses
- •Long-term clenbuterol effects on muscle activity remain unclear and warrant further investigation before drawing conclusions about chronic use in race and performance horses
- •Current findings do not provide evidence that short-term clenbuterol dosing alters the neuromuscular demands or biomechanical efficiency during submaximal work
Key Findings
- •A single dose of clenbuterol (0.80 µg/kg) produced no statistically significant changes in electromyographic amplitude (ARV) or frequency (MF) during submaximal treadmill exercise in Standardbred horses
- •No differences were detected in muscle activity of the extensor carpi radialis, semitendinosus, or longissimus dorsi between clenbuterol and control conditions
- •Short-term clenbuterol administration does not appear to acutely alter neuromuscular activation patterns during submaximal exercise despite being widely used as a bronchodilator in performance horses